Stuttgart - Delayed Quote EUR

PT Kalbe Farma Tbk (LCLA.SG)

Compare
0.0530
-0.0005
(-0.93%)
As of 8:14:12 AM GMT+2. Market Open.
Loading Chart for LCLA.SG
  • Previous Close 0.0535
  • Open 0.0530
  • Bid 0.0565 x 25000000
  • Ask 0.0730 x 25000000
  • Day's Range 0.0530 - 0.0530
  • 52 Week Range 0.0480 - 0.0940
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Apr 29, 2025 - May 5, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: LCLA.SG

View More

Performance Overview: LCLA.SG

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

LCLA.SG
22.63%
IDX COMPOSITE (^JKSE)
8.04%

1-Year Return

LCLA.SG
100.18%
IDX COMPOSITE (^JKSE)
10.25%

3-Year Return

LCLA.SG
100.00%
IDX COMPOSITE (^JKSE)
8.51%

5-Year Return

LCLA.SG
100.00%
IDX COMPOSITE (^JKSE)
40.82%

Compare To: LCLA.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LCLA.SG

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    2.85B

  • Enterprise Value

    2.62B

  • Trailing P/E

    13.93

  • Forward P/E

    13.09

  • PEG Ratio (5yr expected)

    1.20

  • Price/Sales (ttm)

    1.38

  • Price/Book (mrq)

    1.97

  • Enterprise Value/Revenue

    1.47

  • Enterprise Value/EBITDA

    10.37

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LCLA.SG

View More

Company Insights: LCLA.SG

Research Reports: LCLA.SG

View More

People Also Watch